↓ Skip to main content

Immune Checkpoint Inhibitors in the Treatment of HCC

Overview of attention for article published in Frontiers in oncology, January 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
1 news outlet
twitter
4 X users

Citations

dimensions_citation
96 Dimensions

Readers on

mendeley
54 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Immune Checkpoint Inhibitors in the Treatment of HCC
Published in
Frontiers in oncology, January 2021
DOI 10.3389/fonc.2020.601240
Pubmed ID
Authors

Clelia Donisi, Marco Puzzoni, Pina Ziranu, Eleonora Lai, Stefano Mariani, Giorgio Saba, Valentino Impera, Marco Dubois, Mara Persano, Marco Migliari, Andrea Pretta, Nicole Liscia, Giorgio Astara, Mario Scartozzi

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 54 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 11%
Researcher 5 9%
Student > Ph. D. Student 4 7%
Student > Master 4 7%
Student > Doctoral Student 3 6%
Other 9 17%
Unknown 23 43%
Readers by discipline Count As %
Medicine and Dentistry 15 28%
Biochemistry, Genetics and Molecular Biology 8 15%
Immunology and Microbiology 3 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Agricultural and Biological Sciences 1 2%
Other 0 0%
Unknown 26 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 June 2024.
All research outputs
#3,111,943
of 26,184,649 outputs
Outputs from Frontiers in oncology
#796
of 22,918 outputs
Outputs of similar age
#82,263
of 533,721 outputs
Outputs of similar age from Frontiers in oncology
#24
of 651 outputs
Altmetric has tracked 26,184,649 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,918 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 533,721 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 651 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.